Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy versus conventionally fractionated external beam radiotherapy for low- and intermediate-risk prostate cancer

Seok Ho Lee; Hun Jung Kim; Woo Chul Kim

doi:10.1111/ajco.12566

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy versus conventionally fractionated external beam radiotherapy for low- and intermediate-risk prostate cancer

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.12566 ◽

2016 ◽

Vol 12 (4) ◽

pp. 388-395 ◽

Cited By ~ 4

Author(s):

Seok Ho Lee ◽

Hun Jung Kim ◽

Woo Chul Kim

Keyword(s):

Prostate Cancer ◽

Prostate Specific Antigen ◽

Stereotactic Body Radiotherapy ◽

External Beam Radiotherapy ◽

Specific Antigen ◽

External Beam ◽

Intermediate Risk ◽

Risk Prostate Cancer ◽

Conventionally Fractionated

Download Full-text

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer

Prostate International ◽

10.1016/j.prnil.2015.12.001 ◽

2016 ◽

Vol 4 (1) ◽

pp. 25-29 ◽

Cited By ~ 2

Author(s):

Jeong Hoon Phak ◽

Hun Jung Kim ◽

Woo Chul Kim

Keyword(s):

Prostate Cancer ◽

Prostate Specific Antigen ◽

Stereotactic Body Radiotherapy ◽

External Beam Radiotherapy ◽

Specific Antigen ◽

Localized Prostate Cancer ◽

External Beam ◽

Conventionally Fractionated

Download Full-text

The importance of an exponential prostate-specific antigen decline after external beam radiotherapy for intermediate risk prostate cancer

Cancer Epidemiology ◽

10.1016/j.canep.2011.10.007 ◽

2012 ◽

Vol 36 (2) ◽

pp. e137-e141 ◽

Cited By ~ 1

Author(s):

Guila Delouya ◽

Gabriel Kaufman ◽

Marie-Pierre Sylvestre ◽

Thu-Van Nguyen ◽

Jean-Paul Bahary ◽

...

Keyword(s):

Prostate Cancer ◽

Prostate Specific Antigen ◽

External Beam Radiotherapy ◽

Specific Antigen ◽

External Beam ◽

Intermediate Risk ◽

Risk Prostate Cancer

Download Full-text

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy for low- and intermediate-risk prostate cancer

Cancer Treatment Communications ◽

10.1016/j.ctrc.2016.01.001 ◽

2016 ◽

Vol 5 ◽

pp. 46-50

Author(s):

Jeong Hoon Phak ◽

Hun Jung Kim ◽

Woo Chul Kim

Keyword(s):

Prostate Cancer ◽

Prostate Specific Antigen ◽

Stereotactic Body Radiotherapy ◽

Specific Antigen ◽

Intermediate Risk ◽

Risk Prostate Cancer

Download Full-text

Prostate-Specific Antigen Kinetics After Hypofractionated Stereotactic Body Radiation Therapy Boost as Post-External Beam Radiation Therapy (EBRT) Versus Conventionally Fractionated EBRT for Localized Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.06.1318 ◽

2016 ◽

Vol 96 (2) ◽

pp. E276

Author(s):

H.J. Kim ◽

W.C. Kim

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Prostate Specific Antigen ◽

Stereotactic Body Radiation Therapy ◽

Specific Antigen ◽

External Beam Radiation Therapy ◽

External Beam Radiation ◽

External Beam ◽

Beam Radiation ◽

Conventionally Fractionated

Download Full-text

Randomised Phase II Feasibility Trial of Image-guided External Beam Radiotherapy With or Without High Dose Rate Brachytherapy Boost in Men with Intermediate-risk Prostate Cancer (CCTG PR15/ NCT01982786)

Clinical Oncology ◽

10.1016/j.clon.2018.05.007 ◽

2018 ◽

Vol 30 (9) ◽

pp. 527-533 ◽

Cited By ~ 3

Author(s):

E. Vigneault ◽

G. Morton ◽

W.R. Parulekar ◽

T.M. Niazi ◽

C.W. Springer ◽

...

Keyword(s):

Prostate Cancer ◽

External Beam Radiotherapy ◽

High Dose Rate ◽

Feasibility Trial ◽

High Dose ◽

External Beam ◽

Intermediate Risk ◽

Image Guided ◽

Risk Prostate Cancer ◽

Brachytherapy Boost

Download Full-text

Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis

Clinical Oncology ◽

10.1016/j.clon.2021.11.004 ◽

2021 ◽

Author(s):

R.M. Glicksman ◽

A.U. Kishan ◽

A.J. Katz ◽

C.A. Mantz ◽

S.P. Collins ◽

...

Keyword(s):

Prostate Cancer ◽

Prostate Specific Antigen ◽

Response Rate ◽

Specific Antigen ◽

Intermediate Risk ◽

Ablative Therapies ◽

Risk Prostate Cancer

Download Full-text

Absolute percentage of biopsied tissue positive for Gleason pattern 4 disease (APP4) appears predictive of disease control after high dose rate brachytherapy and external beam radiotherapy in intermediate risk prostate cancer

Radiotherapy and Oncology ◽

10.1016/j.radonc.2019.03.007 ◽

2019 ◽

Vol 135 ◽

pp. 170-177 ◽

Cited By ~ 2

Author(s):

K. Martell ◽

L.C. Mendez ◽

H. Chung ◽

C.L. Tseng ◽

L. Zhang ◽

...

Keyword(s):

Prostate Cancer ◽

Disease Control ◽

Dose Rate ◽

External Beam Radiotherapy ◽

High Dose Rate ◽

High Dose ◽

External Beam ◽

Intermediate Risk ◽

Gleason Pattern ◽

Risk Prostate Cancer

Download Full-text

90: Population-Based Analysis of Treatment Factors and Outcomes of Combined Modality Therapy with Low-Dose-Rate Brachytherapy (LDR-PB) Implant with External Beam Radiotherapy (EBRT) for High and Intermediate-Risk Prostate Cancer

Radiotherapy and Oncology ◽

10.1016/s0167-8140(20)30982-8 ◽

2020 ◽

Vol 150 ◽

pp. S40-S41

Author(s):

Justin Oh ◽

Ingrid Spadinger ◽

Vincent Lapointe ◽

James Morris

Keyword(s):

Prostate Cancer ◽

Low Dose ◽

Combined Modality Therapy ◽

External Beam Radiotherapy ◽

Population Based ◽

External Beam ◽

Intermediate Risk ◽

Low Dose Rate ◽

Risk Prostate Cancer ◽

Low Dose Rate Brachytherapy

Download Full-text

Single-Fraction High-Dose-Rate Brachytherapy and Hypofractionated External Beam Radiotherapy for Men With Intermediate-Risk Prostate Cancer: Analysis of Short- and Medium-Term Toxicity and Quality of Life

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.05.054 ◽

2010 ◽

Vol 77 (3) ◽

pp. 811-817 ◽

Cited By ~ 56

Author(s):

Gerard C. Morton ◽

D. Andrew Loblaw ◽

Raxa Sankreacha ◽

Andrea Deabreu ◽

Liying Zhang ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

External Beam Radiotherapy ◽

High Dose Rate ◽

High Dose ◽

External Beam ◽

Intermediate Risk ◽

Medium Term ◽

Risk Prostate Cancer

Download Full-text

Long-Term Oncologic Outcomes of Low Dose Rate Brachytherapy Compared to Hypofractionated External Beam Radiotherapy for Intermediate Risk Prostate Cancer

Brachytherapy ◽

10.1016/j.brachy.2019.04.038 ◽

2019 ◽

Vol 18 (3) ◽

pp. S15-S16

Author(s):

Noelia Sanmamed ◽

Lisa Joseph ◽

Juanita Crook ◽

Jette Borg ◽

Peter Chung ◽

...

Keyword(s):

Prostate Cancer ◽

Low Dose ◽

External Beam Radiotherapy ◽

Oncologic Outcomes ◽

External Beam ◽

Intermediate Risk ◽

Low Dose Rate ◽

Risk Prostate Cancer ◽

Low Dose Rate Brachytherapy

Download Full-text